[Treatment of colorectal cancer: present advances]

Presse Med. 2012 Jan;41(1):44-5. doi: 10.1016/j.lpm.2011.03.022. Epub 2011 Dec 3.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Bevacizumab
  • Carcinoma / pathology
  • Carcinoma / therapy*
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / therapy*
  • Epidermal Growth Factor / antagonists & inhibitors
  • Epidermal Growth Factor / immunology
  • Gastroenterology / methods
  • Gastroenterology / trends*
  • Humans
  • Medical Oncology / methods
  • Medical Oncology / trends*
  • Molecular Targeted Therapy
  • Neoplasm Metastasis

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Bevacizumab
  • Epidermal Growth Factor